G150
Based on 7 publication(s) in Google Scholar
G150 is a highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with an IC50 of 10.2 nM. G150 represses dsDNA-triggered interferon expression, and G150 can be used for the research of inflammatory.
For research use only. We do not sell to patients.
- Purity: 99.20%
- CAS No.: 2369751-30-2
- Formula: C18H16Cl2N4O2
- Molecular Weight:391.25
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) G150
More- Mol Cell. 2023 Jan 14;S1097-2765(22)01217-5. [Abstract]
- Adv Sci (Weinh). 2023 May;10(14):e2206820. [Abstract]
- Cell Death Dis. 2023 Dec 19;14(12):844. [Abstract]
- EMBO J. 2025 Sep 1. [Abstract]
- J Transl Med. 2024 Aug 28;22(1):796. [Abstract]
- Int Immunopharmacol. 2026 May 1:176:116482. [Abstract]
- Toxicol Appl Pharmacol. 2025 Aug 9:504:117502. [Abstract]
Biological Activity
IC50: 10.2 nM (h-cGAS)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
<1 μM
Compound: 51; G150
|
Cytotoxicity against mouse RAW264.7 cells assessed as cell growth inhibition measured after 24 hrs by Celltiter-Glo assay
Cytotoxicity against mouse RAW264.7 cells assessed as cell growth inhibition measured after 24 hrs by Celltiter-Glo assay
|
[PMID: 33984476] |
| THP-1 | IC50 |
1.96 μM
Compound: 51; G150
|
Cytotoxicity against human THP-1 cells assessed as cell growth inhibition measured after 24 hrs by Celltiter-Glo assay
Cytotoxicity against human THP-1 cells assessed as cell growth inhibition measured after 24 hrs by Celltiter-Glo assay
|
[PMID: 33984476] |
| THP-1 | IC50 |
1.96 μM
Compound: 6; G150
|
Cytotoxicity against human THP-1 cells assessed as cell growth inhibition
Cytotoxicity against human THP-1 cells assessed as cell growth inhibition
|
[PMID: 34044539] |
G150 (0.1-100 μM; 1 h) affects IFNB1 and CXCL10 expression in human THP1 cells and primary human macrophages[1]. G150 (5-10 μM; 1 h) affects dsDNA sensing in THP1 cells and primary human macrophages[1]. G150 (0.1-100 μM; 1 h) affects the NF-κB pathway activation in THP1-Dual cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human THP1 cells and primary human macrophages
-
Concentration:0.1-100 μM
-
Incubation Time:1 hour
-
Result:Dose-dependently inhibited IFNB1 and interferon-stimulated genes monitoring CXCL10 expression with IC50s of 1.96 and 7.57 μM respectively in human THP1 cells, and inhibited IFNB1 and CXCL10 expression with IC50s of 0.62 and 0.87 μM respectively in primary human macrophages.
-
Cell Line:Human THP1 cells and primary human macrophages
-
Concentration:5 and 10 μM
-
Incubation Time:1 hour
-
Result:Inhibited dsDNA sensing with a concentration of 10 μM in THP1 cells and with a concentration of 5 μM in primary human macrophages.
-
Cell Line:THP1-Dual cells
-
Concentration:0.1-100 μM
-
Incubation Time:1 hour
-
Result:Inhibited SEAP activity and luciferase activity with IC50s of 0.90 and 1.79 μM respectively in THP1-Dual cells.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2369751-30-2
-
Appearance Solid
-
Molecular Weight 391.25
-
Formula C18H16Cl2N4O2
-
Color White to off-white
-
SMILES
NC1=CC=C(C2=C3C(NC4=C3CN(C(CO)=O)CC4)=C(Cl)C(Cl)=C2)C=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (7)
-
Journal Impact Factor
-
Most Recent
-
Mol Cell
Cytosolic DNA sensing by cGAS/STING promotes TRPV2-mediated Ca2+ release to protect stressed replication forks. [Abstract]2023 Jan 14;S1097-2765(22)01217-5. PMID: 36696898 -
Adv Sci (Weinh)
2023 May;10(14):e2206820. PMID: 36950761 -
Cell Death Dis
2023 Dec 19;14(12):844. PMID: 38114479 -
EMBO J
2025 Sep 1. PMID: 40890487 -
J Transl Med
Blockade of the mitochondrial DNA release ameliorates hepatic ischemia-reperfusion injury through avoiding the activation of cGAS-Sting pathway. [Abstract]2024 Aug 28;22(1):796. PMID: 39198913 -
Int Immunopharmacol
Quercetin alleviates LPS-induced inflammation and immunosuppression in broiler spleen via regulating the mtDNA/cGAS/STING axis. [Abstract]2026 May 1:176:116482. PMID: 41797087 -
Toxicol Appl Pharmacol
Activation of the cGAS-STING pathway in monocytes exacerbates pulmonary fibrosis induced by paraquat poisoning. [Abstract]2025 Aug 9:504:117502. PMID: 40789441
Solvent & Solubility
DMSO : 100 mg/mL (255.59 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (5.32 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (5.32 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (282 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5559 mL | 12.7796 mL | 25.5591 mL | 63.8978 mL |
| 5 mM | 0.5112 mL | 2.5559 mL | 5.1118 mL | 12.7796 mL | |
| 10 mM | 0.2556 mL | 1.2780 mL | 2.5559 mL | 6.3898 mL | |
| 15 mM | 0.1704 mL | 0.8520 mL | 1.7039 mL | 4.2599 mL | |
| 20 mM | 0.1278 mL | 0.6390 mL | 1.2780 mL | 3.1949 mL | |
| 25 mM | 0.1022 mL | 0.5112 mL | 1.0224 mL | 2.5559 mL | |
| 30 mM | 0.0852 mL | 0.4260 mL | 0.8520 mL | 2.1299 mL | |
| 40 mM | 0.0639 mL | 0.3195 mL | 0.6390 mL | 1.5974 mL | |
| 50 mM | 0.0511 mL | 0.2556 mL | 0.5112 mL | 1.2780 mL | |
| 60 mM | 0.0426 mL | 0.2130 mL | 0.4260 mL | 1.0650 mL | |
| 80 mM | 0.0319 mL | 0.1597 mL | 0.3195 mL | 0.7987 mL | |
| 100 mM | 0.0256 mL | 0.1278 mL | 0.2556 mL | 0.6390 mL |